🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/12/2019 | 87,48 | 87,50 | 87,09 | 87,31 | +0,18% | 0,47% | 3.758.966 |
| 26/12/2019 | 87,40 | 87,52 | 86,90 | 87,16 | -0,11% | 0,71% | 3.062.675 |
| 24/12/2019 | 87,44 | 87,53 | 86,90 | 87,25 | -0,33% | 0,72% | 2.343.223 |
| 23/12/2019 | 87,62 | 87,81 | 87,25 | 87,54 | +0,17% | 0,63% | 7.895.946 |
| 20/12/2019 | 87,27 | 88,40 | 86,68 | 87,39 | +1,77% | 1,97% | 17.849.641 |
| 19/12/2019 | 85,77 | 85,96 | 85,39 | 85,87 | +0,41% | 0,67% | 7.602.716 |
| 18/12/2019 | 85,26 | 85,88 | 85,05 | 85,52 | +0,67% | 0,97% | 11.578.199 |
| 17/12/2019 | 85,24 | 85,35 | 84,47 | 84,94 | -0,30% | 1,04% | 11.690.545 |
| 16/12/2019 | 85,54 | 85,88 | 85,10 | 85,20 | +0,11% | 0,91% | 10.355.183 |
| 13/12/2019 | 85,11 | 85,49 | 84,39 | 85,11 | -0,42% | 1,29% | 7.571.800 |
| 12/12/2019 | 84,96 | 85,84 | 84,84 | 85,47 | +0,66% | 1,18% | 6.863.876 |
| 11/12/2019 | 85,06 | 85,39 | 84,78 | 84,90 | -0,13% | 0,72% | 6.821.746 |
| 10/12/2019 | 84,54 | 85,43 | 84,46 | 85,02 | +0,43% | 1,15% | 8.663.711 |
| 09/12/2019 | 84,83 | 84,92 | 84,16 | 84,66 | -0,15% | 0,90% | 8.054.823 |
| 06/12/2019 | 84,92 | 85,15 | 84,69 | 84,78 | +0,11% | 0,55% | 7.245.872 |
| 05/12/2019 | 84,67 | 84,72 | 83,94 | 84,69 | +0,09% | 0,92% | 8.267.462 |
| 04/12/2019 | 83,52 | 84,67 | 83,19 | 84,61 | +1,48% | 1,77% | 7.293.766 |
| 03/12/2019 | 82,71 | 83,46 | 82,54 | 83,38 | +0,39% | 1,12% | 7.466.162 |
| 02/12/2019 | 83,53 | 83,96 | 82,59 | 83,05 | -0,16% | 1,64% | 5.597.997 |
| 29/11/2019 | 83,18 | 83,75 | 83,04 | 83,19 | -0,49% | 0,85% | 4.880.222 |
| 27/11/2019 | 83,40 | 83,85 | 83,01 | 83,60 | +0,31% | 1,01% | 6.037.318 |
| 26/11/2019 | 82,06 | 83,44 | 81,98 | 83,34 | +1,91% | 1,78% | 19.233.420 |
| 25/11/2019 | 82,10 | 82,62 | 81,43 | 81,77 | +0,29% | 1,45% | 9.021.289 |
| 22/11/2019 | 81,73 | 82,40 | 81,41 | 81,54 | -0,01% | 1,21% | 7.800.159 |
| 21/11/2019 | 81,77 | 81,84 | 80,41 | 81,55 | +0,22% | 1,75% | 7.195.568 |
| 20/11/2019 | 80,66 | 81,56 | 80,58 | 81,36 | +0,73% | 1,22% | 8.160.147 |
| 19/11/2019 | 80,53 | 81,06 | 80,12 | 80,77 | +0,62% | 1,16% | 9.691.380 |
| 18/11/2019 | 80,78 | 80,94 | 80,01 | 80,28 | -0,91% | 1,15% | 10.701.757 |
| 15/11/2019 | 80,81 | 81,68 | 80,76 | 81,01 | +0,41% | 1,13% | 9.675.870 |
| 14/11/2019 | 81,03 | 81,28 | 79,87 | 80,68 | -0,32% | 1,74% | 7.911.247 |